Intimations to Stock Exchanges/ Disclosures/ Latest Announcements Home / Investors / Corporate Governance INTIMATIONS TO STOCK EXCHANGES/DISCLOSURES/ LATEST ANNOUNCEMENTS FY 2024-25 Allotment of Equity Shares under the Glenmark Life Sciences Limited Employee Stock Option Scheme, 2021 VIEW Schedule of Analyst Meet – 06th March, 2025 VIEW Intimation of Sad Demise of Independent Director VIEW Regulation 30 Intimation VIEW Schedule of Analyst Meeting – 27th February, 2025 VIEW Regulation 30 Intimation VIEW Schedule of Analyst Meeting- 03rd February, 2025 VIEW Newspaper Publication – Q3FY2025 Result VIEW Integrated Filings (Financials) VIEW Q3 FY25 Earnings Call Invitation – January 23, 2025 VIEW Board Meeting Intimation – January 23, 2025 VIEW Intimation under Regulation 30 of SEBI (LODR), Regulations - Change in Name VIEW Postal Ballot Result & Scrutinizer Report VIEW Schedule of Analyst Meeting – 28th November, 2024 VIEW Schedule of Analyst Meeting – 27th & 28th November, 2024 VIEW Schedule of Analyst Meeting 31st October 2024 VIEW Newspaper Publication – Postal Ballot Notice VIEW Newspaper Publication – Q2FY2025 Result VIEW Schedule of Analyst Meeting 30th October 2024 VIEW Notice of Postal Ballot VIEW Allotment of Equity Shares under the Glenmark Life Sciences Limited Employee Stock Option Scheme,2021 VIEW Related Party Disclosure for the half year ended September 30, 2024 VIEW Disclosure pursuant to Regulation 31A of the SEBI (LODR), 2015– Re-classification from‘Promoter Group’ Category to ‘Public category’ of Glenmark Life Sciences Limited (‘the Company’) VIEW Q2 FY25 Earnings Call Invitation - October 24, 2024 VIEW Board Meeting Intimation - October 24, 2024 VIEW Intimation for change in Company Name VIEW Disclosure under regulation 30 of SEBI (LODR) Regulation, 2015 VIEW 13th AGM Outcome and Scrutinizers Report VIEW Schedule of Analyst Meeting VIEW Newspaper Advertisement for 13th Annual General Meeting VIEW Newspaper Advertisement for 13th Annual General Meeting VIEW Schedule of Analyst Meeting VIEW Notice of 13th Annual General Meeting VIEW 13th AGM Intimation VIEW Schedule of Analyst Meeting VIEW Issue of revocation letter for our Ankleshwar facilityby GPCB VIEW Monitoring Agency Certificate - 30th June 2024 VIEW Schedule of Analyst Meeting - 13th August 2024 VIEW Schedule of Analyst Meeting - 12th August 2024 VIEW Update on Minimum Public Shareholding VIEW Allotment of Equity Shares under the Glenmark Life Sciences Limited Employee Stock Option Scheme,2021 VIEW Newspaper Publication- Unaudited Financial Results for Quarter Ended 30th June, 2024 VIEW Intimation regarding re-appointment of Managing Director and CEO VIEW Regulation 30 - Intimation VIEW Board Meeting intimation- July 25, 2024 VIEW Q1 FY 25 Earnings Calls Intimation – July 26, 2024 VIEW Update on Minimum Public Shareholding VIEW Intimation about Offer for Sale VIEW Disclosure under Regulation 30A of SEBI LODR 2015 VIEW Schedule of Analyst Meeting - 26th to 28th June 2024 VIEW Schedule of Analyst Meeting 27.06.2024 VIEW Credit Rating - India Ratings and Research VIEW Schedule of Analyst Meeting VIEW Schedule of Analyst Meeting VIEW Postal Ballot Result & Scrutinizer report VIEW Schedule of Analyst Meeting VIEW Schedule of Analyst Meeting VIEW Schedule of Analyst Meeting VIEW Schedule of Analyst Meeting VIEW Monitoring Agency Report for the quarter ended March 31, 2024 VIEW Newspaper Publication - Postal Ballot 2024 VIEW Notice of Postal Ballot 2024 VIEW Newspaper Publication- Q4 FY 2023-24 Results VIEW Related Party Disclosure for the half-year endedMarch 31, 2024 VIEW Change in Directorate - Appointment of Additional Director VIEW Change in Directorate - Resignation of Director VIEW Q4 FY 24 Earning Calls Intimation- April 25, 2024 VIEW Board Meeting Intimation - April 25, 2024 VIEW Certificate on Regulation 7(3) VIEW Certificate on Regulation 40(9) VIEW FY 2023-24 Disclosure pursuant to Regulation 31A of the SEBI (LODR) Regulations, 2015 VIEW Disclosure pursuant to Regulation 30(7) of the SEBI (LODR) Regulations, 2015 VIEW Investor Presentation March 2024 VIEW Disclosure pursuant to Regulation 30(7) of SEBI LODR VIEW General Update – Designation of Nirma Limited as a new promoter of the Company VIEW Change in Directorate – Appointments of Additional Directors VIEW Change in Directorate – Resignation of Directors VIEW Monitoring Agency Report for the quarter ended 31st December, 2023 VIEW Newspaper Publication - Recommendations of the Committee of Independent Directors VIEW Newspaper Publication - Unaudited Financial Results for the third quarter and nine months ended 31st December, 2023 VIEW Q3 FY24 Earnings Call Invitation - January 24, 2024 VIEW Board Meeting Intimation – January 23, 2024 VIEW Monitoring Agency Report for the quarter ended 30th September, 2023 VIEW Newspaper Publication - Unaudited Financial Results for the Quarter and half year ended 30th September, 2023 VIEW Related Party Disclosure for the half-year ended September 30, 2023 VIEW Q2 FY24 Earnings Call Invitation - October 20, 2023 VIEW Board Meeting Intimation - October 20, 2023 VIEW Communication sent to shareholders regarding TDSon Dividend VIEW Outcome of the Board Meeting held on October 9, 2023 VIEW Draft Letter of Offer VIEW Board Meeting Intimation VIEW Credit Rating Intimation VIEW AGM Outcome & Scrutinizer Report VIEW Credit Rating Intimation VIEW Outcome of the Board Meeting held on September 21, 2023 VIEW Newspaper Advertisement for 12th Annual General Meeting VIEW Notice of 12th Annual General Meeting VIEW Newspaper Advertisement for 12th Annual General Meeting VIEW 12th AGM Intimation VIEW Monitoring Agency Report for the quarter ended 30th June, 2023 VIEW Newspaper Publication - Unaudited Financial Results for The Quarter Ended 30th June, 2023 VIEW Q1 FY24 Earnings Call Invitation – July 21, 2023 VIEW Board Meeting Intimation – July 21, 2023 VIEW Monitoring Agency Report for the quarter ended 31st March, 2023 VIEW Newspaper Publication Q4FY 2022-23 Results VIEW Related Party Disclosure for the half-year ended March 31, 2023 VIEW Q4 FY23 Earnings Call Invitation - April 28, 2023 VIEW Board Meeting Intimation – April 27, 2023 VIEW Certificate on Regulation 40(9) VIEW Certificate on Regulation 7(3) VIEW FY 2022-23 Board Meeting Outcome – Payment of Interim Dividend VIEW Stock Exchange Intimation – Record Date VIEW Newspaper Publication - Board Meeting - March 16, 2023 VIEW Board Meeting Intimation - March 16, 2023 VIEW Monitoring Agency Report for the quarter ended 31st December, 2022 VIEW Newspaper Publication Q3 FY 2022-23 Results VIEW Q3 FY23 Earnings Call Invitation - January 27, 2023 VIEW Board Meeting Intimation - January 27, 2023 VIEW Postal Ballot Result & Scrutinizer Report dated 3rd January 2023 VIEW Newspaper Advertisement of Postal Ballot Notice - December 2022 VIEW Postal Ballot Notice - December 2022 VIEW Monitoring Agency Report for the quarter ended 30th September, 2022 VIEW Glenmark Life Sciences Limited Investor Day 2022 VIEW Related Party Disclosure for the half-year ended September 30, 2022 VIEW Newspaper Publication Q2 FY 2022-23 Results VIEW Outcome of Board Meeting - Changes to the Board VIEW Q2 FY23 Earnings Call Invitation - October 21, 2022 VIEW Board Meeting Intimation - October 21, 2022 VIEW Outcome of 11th AGM VIEW Newspaper Advertisement of Notice of 11th Annual General Meeting, E-voting Information and Book Closure VIEW Notice of 11th Annual General Meeting VIEW Annual Return FY 2021-22 VIEW Newspaper Advertisement for 11th Annual General Meeting VIEW Intimation of the date of 11th Annual General Meeting and Book Closure VIEW Familiarisation Programme for Independent Directors FY 2021-22 VIEW Monitoring Agency Report for the quarter ended30th June, 2022 VIEW Newspaper Publication Q1 FY 2022-23 Results VIEW Q1 FY23 Earnings Call Invitation – August 5, 2022 VIEW Contact details of personnel authorised to determine Materiality of event and information VIEW Details of Credit Ratings VIEW Intimation of Change of name of the Registrar and Share Transfer Agent VIEW Q4 FY22 Earnings Call Invitation - April 21, 2022 VIEW Board Meeting Newspaper Advertisement – April 20, 2022 VIEW Board Meeting Intimation – April 20, 2022 VIEW Annual Secretarial Compliance Report - March 31, 2022 VIEW Related Party Disclosure for the half-year endedMarch 31, 2022 VIEW Newspaper Publication of Q4 & FY 22 Result VIEW Certificate on Regulation 7(3) VIEW Certificate on Regulation 40(9) VIEW Monitoring Agency Report for the Quarter ended31st March, 2022 VIEW FY 2021-22 Monitoring Agency Report for the Quarter ended31st December, 2021 VIEW Newspaper Publication of Q3 FY 2021-22 Result VIEW Q3 FY22 Earnings Call Invitation - February 9, 2022 VIEW Board Meeting Intimation - February 8, 2022 VIEW Related Party disclosure for the half year ended September 30, 2021 VIEW Monitoring Agency Report for the Quarter ended30th September, 2021 VIEW Newspaper Publication of Q2 FY 2021-22 Result VIEW Stock Exchange Intimation - Board may consider Interim Dividend VIEW Intimation - Q2 FY 2021 - 22 Result Earnings Call VIEW Minutes of the proceedings of Postal Ballot VIEW Board Meeting Intimation VIEW Voting Result of Postal Ballot and Scrutinizer’s Report VIEW Postal Ballot - Newspaper Advertisement VIEW Postal Ballot Notice VIEW Annual Return FY 2020-21 VIEW Newspaper Publication of Q1 FY 2021-22 Result - Loksatta Pune VIEW Newspaper Publication of Q1 FY 2021-22 Result - Financial Express VIEW Q1 FY22 Earnings Call Invitation - August 16, 2021 VIEW Board meeting intimation - August 13, 2021 VIEW
